Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression
1998

p53 and Angiogenesis in Lung Cancer

publication Evidence: moderate

Author Information

Author(s): G Fontanini

Primary Institution: University of Pisa

Hypothesis

What is the relationship between p53 expression and prognosis in non-small-cell lung cancer?

Conclusion

The study suggests a complex relationship between p53 alterations and prognosis in non-small-cell lung cancer, with some studies indicating poor prognosis while others suggest a favorable outcome.

Supporting Evidence

  • Some studies show p53 alterations are linked to poor prognosis in lung cancer.
  • Other studies suggest p53 may not always indicate a bad outcome.
  • Vascular count in tumors has been associated with poor prognosis.

Takeaway

This study looks at how a protein called p53 affects lung cancer and its blood vessel growth, showing that sometimes it can mean bad news for patients, but other times it might not.

Methodology

The study evaluated vascular count in tumor areas with the highest number of microvessels and analyzed the relationship between p53 and vascular count.

Potential Biases

Potential biases may arise from the use of retrospective cohorts.

Limitations

The study acknowledges discrepancies in findings due to different patient cohorts, tumor stages, histological types, and methodologies used in various studies.

Statistical Information

P-Value

0.01

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication